Post Date: April 1, 2021
Prior to joining Vertex Pharmaceuticals, Dr. Altshuler was one of four founding members of the Broad Institute of Harvard and MIT, launched in 2004.
His research track record includes leading roles with the SNP Consortium, the International HapMap Project, and the 1000 Genomes Project. His laboratory contributed to mapping dozens of gene risk variants associated with Type 2 Diabetes, myocardial infarction, rheumatoid arthritis, lupus, prostate cancer, and other disorders.
We are honored to present Dr. Altshuler as the next speaker in the Cincinnati Children’s Envisioning Our Future For Children speaker series.
The Research Horizons blog features news and insights about the latest discoveries and innovations developed by the scientists of Cincinnati Children's. This blog does not provide medical advice, diagnosis, or treatment.